The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting

Depending on the site of irradiation, about 40-80% of patients undergoing radiotherapy (RT) will experience nausea and/or vomiting. The current study aimed to investigate the efficacy of ondansetronas as a single agent and with a combination to aprepitant on preventing RT-induced nausea and vomiting (RINV).In a clinical randomized controlled trial (from September 2010 to September 2011), conducted in Radiation Oncology Department of...